SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Brenner H, Stegmaier C, Ziegler H. Magnitude and time trends of the lifetime risk of developing cancer in Saarland, Germany. Eur J Cancer. 1990; 26: 978982.
  • 2
    Schouten LJ, Straatman H, Kiemeney L, Verbeek A. Cancer incidence—life table risk versus cumulative risk. J Epidemiol Commun Health. 1994; 48: 596600.
  • 3
    Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. J Natl Cancer Inst. 1993; 85: 892897.
  • 4
    Moreno V, Sanchez V, Galceran J, Borras JM, Borras J, Bosch FX. Risk of developing cancer and dying from cancer in Catalonia (Spain). Med Clin. 1998; 110: 8693.
  • 5
    Merrill RM, Kessler GL, Udler JM, Rasband GC, Feuer EJ. Comparison of risk estimates for selected diseases and causes of death. Prev Med. 1999; 28: 179193.
  • 6
    Nazario CM, Figueroa-Valles N, Rosario RV. Breast cancer patterns and lifetime risk of developing breast cancer among Puerto Rican females. P R Health Sci J. 2000; 19: 713.
  • 7
    RiesLAG, EisnerMP, KosaryCL, et al., editors. SEER cancer statistics review, 1975–2000. Bethesda: National Cancer Institute, 2003. Available from URL: http://seer.cancer.gov/csr/1975_2000 [accessed March 8, 2005].
  • 8
    American Cancer Society. Cancer facts and figures 2004. Atlanta: American Cancer Society, 2004. Available from URL: http://www.cancer.org/docroot/STT/stt_0.asp [accessed March 8, 2005].
  • 9
    National Cancer Institute. DevCan—Probability of developing or dying of cancer. Available from URL: http://srab.cancer.gov/devcan [accessed March 8, 2005].
  • 10
    Fay MP, Pfeiffer R, Cronin KA, Le C, Feuer EJ. Age-conditional probabilities of developing cancer. Stat Med. 2003; 22: 18371848.
  • 11
    National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat database: incidence—SEER 14 Regs, November 2002 submission to simulate the racial/ethnic monograph by race (1988–1992, 1990 populations by 5; released October 2003 based on the November 2002 submission). Bethesda: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2003.
  • 12
    National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat database: incidence—SEER 11 Regs + RG, November 2002 submission to simulate the racial/ethnic monograph by origin (1988–1992, 1990 populations by 5; released October 2003 based on the November 2002 submission). Bethesda: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2003.
  • 13
    National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat database: mortality—all COD, total U.S. to simulate the racial/ethnic monograph by race (1988–1992, 1990 populations by 5; released October 2003). Bethesda: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2003. Underlying mortality data provided by NCHS. Available from URL: http://www.cdc.gov/nchs [accessed October 7, 2004].
  • 14
    National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat database (www.seer.cancer.gov): mortality—all COD, total U.S. to simulate the racial/ethnic monograph by origin (1988–1992, 1990 pops by 5; released October 2003). Bethesda: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2003. Underlying mortality data provided by NCHS. Available from URL: http://www.cdc.gov/nchs [accessed October 7, 2004].
  • 15
    MillerBA, KolonelLN, BernsteinL, et al., editors. Racial/ethnic patterns of cancer in the United States 1988–1992. Pub. No. 96-4104. Bethesda: National Cancer Institute, 1996.
  • 16
    Department of the Interior, Bureau of Indian Affairs. Indian entities recognized and eligible to receive services from the United States Bureau of Indian Affairs. Fed Reg. 2002; 67: 4632846333.
  • 17
    Cobb N, Paisano RE. Patterns of cancer mortality among Native Americans. Cancer. 1998; 83: 23772383.
  • 18
    Centers for Disease Control and Prevention, National Center for Health Statistics. Mortality data from the National Vital Statistics System. Mortality Technical Appendix, 1989. Available from URL: http://www.cdc.gov/nchs/datawh/statab/pubd/ta.htm [accessed March 8, 2005].
  • 19
    National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. Policy for calculating Hispanic mortality. Available from URL: http://seer.cancer.gov/seer-stat/variables/mort/origin_recode_1990+/yr1969_2001/ [accessed March 8, 2005].
  • 20
    Fay MP. Estimating age-conditional probability of developing cancer using a piecewise mid-age joinpoint model for the rates (Technical Report 2003-03). Bethesda: Statistical Research and Applications Branch, National Cancer Institute, 2003.
  • 21
    Wun Lap-Ming, Merrill RM, Feuer EJ. Estimating lifetime and age-conditional probabilities of developing cancer. Lifetime Data Anal. 1998; 4: 169186.
  • 22
    U.S. Cancer Statistics Working Group. United States Cancer statistics: 1999–2001 incidence and mortality web-based report version. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2004. Available from URL: http://www.cdc.gov/cancer/npcr/uscs [accessed March 8, 2005].
  • 23
    Cobb N, Paisano RE. Patterns of cancer mortality among Native Americans. Cancer. 1998; 83: 23772383.
  • 24
    Espy D, Paisano R, Cobb N. Regional patterns and trends in cancer mortality among American Indians and Alaska Natives, 1990–2001. Cancer. 2005; 103: 10451053.
  • 25
    Lu-Yao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet. 1994; 343: 251254.
  • 26
    Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995; 273: 548552.
  • 27
    Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control. 1998; 9: 519527.
  • 28
    Hankey BF, Feuer EJ, Clegg LX, et al. Cancer surveillance series: interpreting trends in prostate cancer—Part I: evidence of the effects of screening in recent prostate cancer incidence mortality, and survival rates. J Natl Cancer Inst. 1999; 91: 10171024.
  • 29
    Etzioni R, Berry KM, Legler JM, Shaw P. Prostate-specific antigen testing in black and white men: an analysis of Medicare claims from 1991–1998. Urology. 2002; 59: 251255.
  • 30
    Sarma AV, Schottenfeld D. Prostate cancer incidence, mortality, and survival trends in the United States: 1981–2001. Semin Urol Oncol. 2002; 20: 39.
  • 31
    National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. DevCan database: “SEER 9 incidence and mortality, 1975–2000, follow-back year = 1973” (released April 2003 based on the November 2002 submission). Bethesda: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2003. Underlying mortality data provided by NCHS. Available from URL: http://www.cdc.gov/nchs [accessed October 7, 2004].
  • 32
    Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989; 81: 18791886.
  • 33
    Frost F, Shy KK. Racial differences between linked birth and infant death records in Washington State. Am J Public Health. 1980; 70: 974976.
  • 34
    Blustein J. The reliability of racial classifications in hospital discharge abstract data. Am J Public Health. 1994; 84: 10181021.
  • 35
    Kwong SL, Perkins CI, Snipes KP, Wright WE. Improving American Indian cancer data in the California cancer registry by linkage with the Indian Health Service. J Registry Manage. 1998; 25: 1720.
  • 36
    Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins CNH, McPhee SJ. Accuracy of racial classification of Vietnamese patients in a population-based cancer registry. Ethn Dis. 1998; 8: 218227.
  • 37
    Rosenberg HM, Maurer JD, Sorlie PD, et al. Quality of death rates by race and Hispanic origin: a summary of current research, 1999. National Center for Health Statistics. Vital Health Stat. 1999; 128: 113.
  • 38
    Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW. Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol. 1999; 149: 10631071.
  • 39
    Harwell TS, Hansen D, Moore KR, Jeanotte D, Gohdes D, Helgerson SD. Accuracy of race coding on American Indian death certificates, Montana 1996–1998. Public Health Rep. 2002; 117: 4449.
  • 40
    Parker JD, Schenker N, Ingram DD, Weed JA, Heck KE, Madans JH. Bridging between two standards for collecting information on race and ethnicity: an application to Census 2000 and vital rates. Public Health Rep. 2004; 119: 192205.
  • 41
    U.S. Census Bureau. United States Census 2000. Special tabulations disclosure review board rules/requirements. Available from URL: http://www.census.gov/population/www/cen2000/sptabs/disclosure.html. [accessed March 8, 2005].